QPS

QPS is a contract research organization offering comprehensive services across the drug development lifecycle. The company provides bioanalysis services including assay development, biomarkers and translational medicine, biotherapeutics analysis, cell and gene therapy support, flow cytometry, genomics, and small molecule analysis. Preclinical capabilities include DMPK studies, biotransformation, drug-drug interaction studies, protein binding, radiolabeled ADME, IND package preparation, pharmacology, and toxicology services. Clinical services encompass early-stage and late-phase clinical trials, clinical research services, project management and site monitoring, site identification and qualification, medical affairs, medical writing, pharmacovigilance, regulatory affairs, clinical biostatistics, data management, study recruitment, and real-world evidence studies. The organization maintains therapeutic area expertise in dermatology (including dermal and transdermal research), endocrinology, inflammatory bowel disease, neuropsychiatry, obesity, oncology, rheumatology, vaccines, and women's health. QPS operates a global footprint with locations across the USA (Delaware, Miami, Missouri), Europe (The Netherlands, Austria), Taiwan (multiple facilities including CTPS, NKSP, and Qualitix), and India.